Evidence map›Paper›PMID 42644872›Full record

ArticleAdvances in respiratory medicine2026

Interstitial Lung Disease in the United States: CDC Mortality Trends (1999-2024).

Palak Grover, Rahul Jain, Gurleen Kaur, Bipneet Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in respiratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Palak GroverDepartment of Internal Medicine, Henry Ford Jackson Hospital, Jackson, MI 49201, USA.
Rahul JainDepartment of Internal Medicine, Sri Manakula Vinayagar Medical College, Puducherry 605107, India.
Gurleen KaurDepartment of Internal Medicine, Government Medical College, Amritsar 143001, India.
Bipneet SinghDepartment of Gastroenterology, University of Kentucky, Lexington, KY 40506, USA.ORCID 0009-0008-6147-9584

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial lung diseases (ILDs) comprise a heterogeneous group of pulmonary disorders associated with substantial morbidity and mortality. We examined mortality attributed to selected J84-coded ILDs in the United States from 1999 to 2024 using CDC WONDER underlying-cause-of-death data. Age-adjusted mortality rates (AAMRs) per 100,000 population were standardized to the 2000 U.S. population and stratified by sex and race. Joinpoint regression was used to identify changes in temporal slope and estimate annual percent change (APC), average annual percent change (AAPC), 95% confidence intervals (CIs), and

Indexed as

Lung Diseases, InterstitialAgedCause of DeathCenters for Disease Control and Prevention, U.S.FemaleHumansMaleMiddle AgedMortalityUnited Statesidiopathic pulmonary fibrosisinterstitial lung diseasesystemic sclerosis

Identifiers

PMID42644872
PMCPMC13509682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.